
MHRA approves Bavarian Nordic’s chikungunya vaccine Vimkunya
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed) to prevent disease caused by the chikungunya virus in individuals aged 12 years and older. Chikungunya is a mosquito-borne viral …